Prosenex Ambulatorium Betriebsgmbh

Where the EU money came from

Funding by EU programme. Amounts are Prosenex Ambulatorium Betriebsgmbh's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• NEXGEN-PDPartner

  Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €401ktheir share
• SYMPATHPartner

  Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €366ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Forschungszentrum Julich GmbHGermany · 1 shared project
• Philipps Universitaet MarburgGermany · 1 shared project
• Medizinische Universitat InnsbruckAustria · 1 shared project
• Centre Hospitalier Universitaire de ToulouseFrance · 1 shared project
• Paracelsus Medizinische Privatuniversitat Salzburg - PrivatstiftungAustria · 1 shared project
• Chu Hopitaux de BordeauxFrance · 1 shared project
• Affiris AGAustria · 1 shared project
• Modus Research and Innovation LimitedUnited Kingdom · 1 shared project
• Biolution GmbHAustria · 1 shared project
• Tridem Bioscience GmbH & Co KGAustria · 1 shared project
• Institute for Medical Technology Assessment BVNetherlands · 1 shared project
• Aurigon Labs Zartkoruen Mukodo ReszvenytarsasagHungary · 1 shared project
• Motac FranceFrance · 1 shared project
• Austrian Red Cross Research GmbHAustria · 1 shared project
• Gouya Insights GmbH & Co KGAustria · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• drug discovery
• neurobiology
• parkinson
• pathology
• vaccines